Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2003
03/06/2003CA2456828A1 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
03/06/2003CA2455883A1 Anti-cancer and wound healing compounds
03/06/2003CA2446547A1 Combinations of genes for producing seed plants exhibiting modulated reproductive development
03/06/2003CA2421442A1 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof
03/05/2003WO2002020566A2 NOVEL MMP-2 DERIVATIVES FOR USE AS INHIBITORS OF INTEGRIN αVβ¿3?
03/05/2003EP1288310A1 Use of SNPs of MCH-R for identifying genetic disorders in maintaining the normal body weight
03/05/2003EP1288304A2 Self-assembled, defective, non-self-propagating viral particles
03/05/2003EP1288303A1 Inducible expression systems employing PPAR transcriptional activators
03/05/2003EP1288302A1 Rice regulatory sequences for gene expression in defined wheat tissue
03/05/2003EP1288301A1 Plant-derived resistance gene
03/05/2003EP1288292A1 Long peptides of 22-40 amino acid residues that induce and/or enhance antigen specific immune responses.
03/05/2003EP1288228A1 BMP-2-derived peptides having osteogenetic activity and osteogenetic accelerator containing the same
03/05/2003EP1288227A1 Coactivator of nuclear receptors
03/05/2003EP1288226A1 Modification of the expression levels of Toll-like receptor familiy members for influencing neurodegeneration and neuroprotection in the human central nervous system
03/05/2003EP1288224A1 Therapeutic peptide derivatives
03/05/2003EP1288223A1 Therapeutic peptide derivatives
03/05/2003EP1288222A1 Peptidic compounds selectively binding to P-selectin
03/05/2003EP1288221A1 Oligopeptides
03/05/2003EP1287362A2 Compositions and methods for modulating tumor specific expression
03/05/2003EP1287355A2 Methods and compounds for influencing $g(b)3 integrin-dependent intracellular processes
03/05/2003EP1287161A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
03/05/2003EP1287152A2 Human-bovine chimeric respiratory syncytial virus vaccines
03/05/2003EP1287147A2 Immunotoxin fusion proteins and means for expression thereof
03/05/2003EP1287144A2 Bacterial insecticidal proteins
03/05/2003EP1287143A2 Corynebacterium glutamicum nucleotide sequences coding for the glbo gene
03/05/2003EP1287142A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
03/05/2003EP1287141A2 Extracellular messengers
03/05/2003EP1287139A2 Synthetic spider silk proteins and the expression thereof in transgenic plants
03/05/2003EP1287138A1 Novel g-protein coupled receptor
03/05/2003EP1287137A2 REGULATION OF HUMAN $g(a)1A?ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
03/05/2003EP1287136A1 Modified chemokine receptor ccr-3 and assay
03/05/2003EP1287135A2 Regulation of human follicle stimulating hormone-like g protein-coupled receptor
03/05/2003EP1287134A2 The human voltage-gated sodium channel beta-1a subunit and methods of use
03/05/2003EP1287133A2 Regulation of human dopamine-like g protein-coupled receptor
03/05/2003EP1287132A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/05/2003EP1287131A2 Regulator of g protein signalling (rgs8)
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287128A2 Myc targets
03/05/2003EP1287127A2 Regulation of human histamine h2-like g protein-coupled receptor
03/05/2003EP1287125A2 Dna sequences encoding dystrophin minigenes and methods of use thereof
03/05/2003EP1287121A2 Extracellular domain of ryk protein for regulating angiogenesis
03/05/2003EP1287034A2 Derivatives of breast cancer antigen her-2 for therapeutical use
03/05/2003EP1287033A2 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
03/05/2003EP1287032A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/05/2003EP1287031A2 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
03/05/2003EP1287030A1 Insulin regulated substance (irs-2) induced by pioglitazone, assay and use thereof
03/05/2003EP1287029A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287028A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287027A2 Control of tgf(beta) signaling by km23 superfamily members
03/05/2003EP1287026A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
03/05/2003EP1287025A1 Sheep lice, bovicola ovis, allergen treatment
03/05/2003EP1287024A2 Virulence genes, proteins, and their use
03/05/2003EP1287023A1 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
03/05/2003EP1287022A2 Human ion channels
03/05/2003EP1287021A2 Human galanin receptor-like g protein coupled receptor
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
03/05/2003EP1287015A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
03/05/2003EP1287014A1 Enhanced protein thermostability and temperature resistance
03/05/2003EP1287013A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
03/05/2003EP1286694A2 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286684A2 Cxcr4 antagonist treatment of hematopoietic cells
03/05/2003EP1286677A1 Purified material having size and growth inhibitory effects on cells and tissues
03/05/2003EP1286590A2 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof
03/05/2003EP1108058A4 Evolution of whole cells and organisms by recursive sequence recombination
03/05/2003EP1069907A4 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS
03/05/2003EP0932417B1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
03/05/2003EP0928197B1 Use of proteins as agents against autoimmune diseases
03/05/2003EP0845034B1 peptide having pronociceptive properties
03/05/2003EP0835262B1 Method for the treatment of corticosteroid induced osteopenia
03/05/2003EP0804254B1 Heat treated blood plasma proteins
03/05/2003EP0791009A4 Modified neuropeptide y receptors
03/05/2003EP0759942B1 Interleukin-15 receptors
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0674704B1 NOVEL $i(BACILLUS THURINGIENSIS) STRAINS ACTIVE AGAINST LEPIDOPTERAN AND COLEOPTERAN PESTS
03/05/2003EP0669913B1 Detection of hypoxia
03/05/2003EP0667784B1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
03/05/2003EP0656952B1 Cationic peptides and method for production
03/05/2003EP0625157B1 PLATELET GPIIIa P1A1 AND P1A2 EPITOPES, THEIR PREPARATION AND USE
03/05/2003EP0602126B1 Immunoglobulin variants for specific fc epsilon receptors
03/05/2003CN1401004A Alteration of growth and adaptation under hypoxic conditions
03/05/2003CN1401003A Gene Sp17 inhibiting lesion formation in plant and utilization thereof
03/05/2003CN1401002A Dehiscence gene and methods for regulating dehiscence
03/05/2003CN1401001A 5HT3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof
03/05/2003CN1400977A A novel human cell cysle control related protein and a sequence encoding the same
03/05/2003CN1400910A Factor VII or VIIa like molecules
03/05/2003CN1400907A 9M-negative EHV-mutants
03/05/2003CN1400313A Method for producing recombinant human epidermal growth factor by using gene engineering colibacillus
03/05/2003CN1400309A Large wasp sedative peptide precursor gene and its coded polypeptide and preparation method
03/05/2003CN1400308A Transcription factor from prunella asiatica, gene coding said factor and method for cultivating plant with adverse resistance
03/05/2003CN1400305A Recombinant acid fibroblast growth factor (aFGF) gene engineering bacterium and method for preparing recombinant aFGF by using said bacterium
03/05/2003CN1400221A Recombination method of substrate mediated membrane protein in lipid bilayer
03/05/2003CN1400220A Two kinds of cDNA with activity capable of extensively inhibiting HIV and its expression, separation and purification method in protokaryon
03/05/2003CN1400219A Amino acid polypeptide with strong membrane-inserting capability
03/05/2003CN1102659C Recombinant baculovirus insecticides
03/05/2003CN1102598C Peptides derived from human heat shock protein 60, compositions and application thereof
03/05/2003CN1102594C Agent for suppressing interferencein immuno assaying
03/05/2003CN1102382C Preparation and methods for the treatment of T cell mediated diseases
03/05/2003CA2421283A1 Novel mmp-2 derivatives for use as inhibitors of integrin .alpha.v.beta.3
1 ... 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 ... 2916